UK markets closed

AB Science S.A. (0Q77.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.5310-0.0740 (-2.84%)
At close: 05:08PM GMT

AB Science S.A.

3, avenue George V
Paris 75008
France
33 1 47 20 00 14
https://www.ab-science.com

Sector(s)
Industry
Full-time employees89

Key executives

NameTitlePayExercisedYear born
Mr. Alain Moussy MBACo-Founder, Chairman, President, CEO, MD & Scientific Director596kN/AN/A
Mr. Laurent Guy MBAChief Financial OfficerN/AN/AN/A
Mr. Christian FASSOTTEGlobal Chief Medical OfficerN/AN/AN/A
Mr. Alexis BERNARDHead of Veterinary SalesN/AN/AN/A
Mr. Harshad KULKARNIHead of StatisticsN/AN/AN/A
Dr. Albert Ahn D.V.M.President of USA OperationsN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

Corporate governance

AB Science S.A.’s ISS governance QualityScore as of 1 March 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.